- Not enactedThe President has not signed this bill
- The senate has not voted
- The house has not voted
Committee on Energy and CommerceCrime, Terrorism and Homeland SecurityIntroducedSeptember 12th, 2019
- house Committees
Rescheduling marijuana as a schedule III drug would lower barriers to research into its potential benefits and medical uses by allowing federal funding for those efforts. It would also benefit legal marijuana businesses, which face a number of legal and regulatory issues related to marijuana’s schedule I status.
Marijuana’s current schedule I status doesn’t prevent research on its potential benefits and medical uses. Rescheduling would be largely symbolic from a research perspective, as it doesn’t affect legality — for example, cocaine is schedule II and illegal — so there’s no reason to reschedule marijuana as long as research can move ahead.